Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 15889-32-4 | MDL No. : | MFCD00956760 |
Formula : | C11H10N2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YLNMGMIEOWFPRX-UHFFFAOYSA-N |
M.W : | 170.21 | Pubchem ID : | 459517 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 54.08 |
TPSA : | 38.91 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.95 cm/s |
Log Po/w (iLOGP) : | 1.63 |
Log Po/w (XLOGP3) : | 1.95 |
Log Po/w (WLOGP) : | 2.34 |
Log Po/w (MLOGP) : | 1.47 |
Log Po/w (SILICOS-IT) : | 2.31 |
Consensus Log Po/w : | 1.94 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.74 |
Solubility : | 0.309 mg/ml ; 0.00182 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.39 |
Solubility : | 0.69 mg/ml ; 0.00406 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.18 |
Solubility : | 0.0113 mg/ml ; 0.0000665 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.73 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338-P310 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
42% | With potassium carbonate In 1,2-dimethoxyethane; water at 80℃; | REFERENCE EXAMPLE 31; 2-(3-Aminophenyl)pyridine; To a suspension of 2-bromopyridine (0.5 g, 3.2 mmol), 3-aminophenylboronic acid (0.49 g, 3.2 mmol), anhydrous K2CO3 (0.87 g, 6.3 mmol) and Pd(PPh3J4 (0.36 g, 0.32 mmol) in 1 ,2-dimethoxyethane (50 mL) under argon, water (0.66 mL) was added. The mixture was heated under argon at 80 °C overnight. It was allowed to cool and water and EtOAc were added. The phases were separated and the aqueous phase was reextracted with EtOAc. The combined organic phases were dried over Na2SO4 and the solvent was evaporated. The crude product obtained was purified by chromatography on silica gel using hexane-EtOAc mixtures of increasing polarity as eluent, to afford 0.22 g of the title compound (yield: 42percent). LC-MS (method 1): tR = 1.46 min; m/z = 171.2 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | With potassium carbonate; hydrazine hydrate In water; N,N-dimethyl-formamide at 80℃; for 9 h; | General procedure: Aryl halide (1.0 mmol), phenylboronic acid (1.1 mmol),K2CO3(2.0 mmol), Ni7–Pd3BIHPS (0.03 g) and H2O/DMF (2:1, 3 mL) were mixed and heated at 80 °C for anappropriate time (monitored by TLC). Then, hydrazinehydrate (80 wtpercent, 6 eq) was added to the reaction vessel.After completion of the reduction process, the mixturewas filtered and washed with water. The organic layer wasextracted with ethyl acetate (3 × 15 mL) and dried overMgSO4.Then the organic solution was concentrated andpurified by column chromatography to obtain the finalproduct. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
64% | With tetrakis(triphenylphosphine) palladium(0) In toluene for 12 h; Reflux | To a 500 ml round bottom flask was added 20.0 g (116 mmol) of 3-bromoaniline,85.6 g (233 mmol) of 2- (tributylstannyl) pyridine,1.34 g (116 mmol) of tetrakistriphenylphosphine palladium,200 ml of toluene was added and the mixture was refluxed for 12 hours.After completion of the reaction, the temperature was cooled down to room temperature.The organic layer was extracted with ethyl acetate and water and concentrated under reduced pressure.Column purification was carried out using ethyl acetate and n-hexane as eluent. (12.7 g, yield 64percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
37% | With sodium carbonate In 1,2-dimethoxyethane; water for 5 h; Reflux | (i) 3-(Pyridin-2-yl)aniline 3.72 g (20.0 mmol) of 3-aminophenyl boronic acid* hemisulphate salt, 3.16 g (20.0 mmol) of 2-bromopyridine, 1.16 g (1.0 mmol) of tetrakis(triphenyl phosphine)palladium(0), and 11.2 g (106 mmol) of sodium carbonate were heated under reflux for 5 hours in a mixed solvent of 100 mL of DME and 34 mL of water. After completion of the reaction, extraction with ethyl acetate, and drying over anhydrous sodium sulfate were carried out. The solvent was distilled off under reduced pressure. The resulting crude product was separated and purified using silica gel column chromatography to give 1.27 g of 3-(pyridin-2-yl)aniline (yield: 37percent). 1H-NMR (CDCl3) δ: 3.76 (2H, br), 6.65-6.78 (1H, m), 7.10-7.40 (4H, m), 7.60-7.78 (2H, m), 8.60-8.70 (1H, m). |
[ 1170936-92-1 ]
3-(Pyridin-2-yl)aniline dihydrochloride
Similarity: 0.98
[ 1170936-92-1 ]
3-(Pyridin-2-yl)aniline dihydrochloride
Similarity: 0.98
[ 1498333-87-1 ]
(4-(Pyridin-2-yl)phenyl)methanamine hydrochloride
Similarity: 0.86
[ 1170936-92-1 ]
3-(Pyridin-2-yl)aniline dihydrochloride
Similarity: 0.98